Page last updated: 2024-08-26

methyllycaconitine and Alzheimer Disease

methyllycaconitine has been researched along with Alzheimer Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Abdallah, DM; Ahmed, KA; El-Abhar, HS; El-Brairy, AI; Mohamed, RA1
Huang, SH; Jong, A; Li, L; Liu, L; Mao, DA; Wu, CH; Yu, J; Zhang, B1
Freir, DB; Herron, CE1
Marszalec, W; Moriguchi, S; Narahashi, T; Yeh, JZ; Zhao, X1
Buccafusco, JJ; Jonnala, RR1

Other Studies

5 other study(ies) available for methyllycaconitine and Alzheimer Disease

ArticleYear
Palonosetron/Methyllycaconitine Deactivate Hippocampal Microglia 1, Inflammasome Assembly and Pyroptosis to Enhance Cognition in a Novel Model of Neuroinflammation.
    Molecules (Basel, Switzerland), 2021, Aug-21, Volume: 26, Issue:16

    Topics: Aconitine; Alzheimer Disease; Amyloid beta-Peptides; Animals; CARD Signaling Adaptor Proteins; Cognition; Diet, Western; Disease Models, Animal; Hippocampus; Humans; Inflammasomes; Inflammation; Insulin Resistance; Interleukin-18; Lipopolysaccharides; Microglia; Palonosetron; Peptide Fragments; Pyroptosis; Rats; Receptors, Serotonin, 5-HT3; Risk Factors; Spatial Memory

2021
Alpha7 nicotinic acetylcholine receptor is required for amyloid pathology in brain endothelial cells induced by Glycoprotein 120, methamphetamine and nicotine.
    Scientific reports, 2017, 01-11, Volume: 7

    Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Biomarkers; Blood-Brain Barrier; Brain; Cell Movement; Cellular Senescence; Endothelial Cells; HIV Envelope Protein gp120; HL-60 Cells; Humans; Methamphetamine; Mice, Inbred C57BL; Monocytes; Nicotine; Protein Transport; Receptor for Advanced Glycation End Products; S100 Proteins; Time Factors

2017
Nicotine enhances the depressive actions of A beta 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo.
    Journal of neurophysiology, 2003, Volume: 89, Issue:6

    Topics: Aconitine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Electrophysiology; Hippocampus; Injections, Intraventricular; Long-Term Potentiation; Male; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Peptide Fragments; Rats; Rats, Wistar; Receptors, Nicotinic

2003
Unique mechanism of action of Alzheimer's drugs on brain nicotinic acetylcholine receptors and NMDA receptors.
    Life sciences, 2003, Dec-05, Volume: 74, Issue:2-3

    Topics: Acetylcholine; Aconitine; Alzheimer Disease; Animals; Brain Chemistry; Bungarotoxins; Dihydro-beta-Erythroidine; Female; GTP-Binding Proteins; Hexamethonium; Mecamylamine; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents; Patch-Clamp Techniques; Pregnancy; Protein Kinases; Pyrrolidinones; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic

2003
Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
    Journal of neuroscience research, 2001, Nov-15, Volume: 66, Issue:4

    Topics: Acetylcholine; Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Animals; Basal Nucleus of Meynert; Binding Sites; Binding, Competitive; Bungarotoxins; Cell Survival; Dose-Response Relationship, Drug; Insecticides; Iodine Radioisotopes; Models, Biological; Nerve Growth Factors; Neurons; Neuroprotective Agents; Nicotinic Agonists; Nicotinic Antagonists; PC12 Cells; Rats; Receptors, Nicotinic; Up-Regulation

2001